消化道炎分离表面与粘膜状:一种罕见且未被认可的临床表现
Amani Altaiam1, Husam Saffo2, Yousef Yahia2
1Family Medicine, Primary Health Care Corporation, Doha, QAT.
Cureus
|January 14, 2026
概括
粘膜主导的黄道 (PV) 可以导致没有皮肤病变的表面性食道炎 (EDS). 早期诊断和皮质类固醇治疗对于管理这种罕见的胃肠道疾病至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 消化道炎 (ESohagitis dissecans superficialis,简称EDS) 是一种罕见的脱皮性食道疾病.
- 它通常与化学,热或药物损伤,或像pemphigus vulgaris (PV) 这样的突发性自身免疫性疾病有关.
研究的目的:
- 报告一种带有口腔和症状EDS的粘膜主导PV病例.
- 以突出诊断挑战和治疗结果在这种情况下.
主要方法:
- 一个病例报告详细介绍了一个患有口腔和EDS的患者.
- 诊断方法包括口腔粘膜活检和血清抗皮质IgG抗体测试.
- 治疗包括全身性皮质类固醇.
主要成果:
- 患者出现了渐进的口腔和症状EDS,但没有皮肤病变.
- 口腔活检证实了超基底性乙溶解;血清IgG抗体呈阳性.
- 系统性皮质类固醇导致了快速的临床改善.
结论:
- 粘膜主导的PV应考虑在患有持续口腔和胃肠道症状不响应初始治疗的患者.
- 这一案例强调了对EDS进行综合诊断方法的重要性.
相关概念视频
Esophageal Perforation-II: Clinical Manifestations and Management
494
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
494
Barrett Esophagus-II: Clinical Manifestations and Management
786
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
786
Peptic Ulcer Disease I: Introduction
740
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
740
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
534
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
534
Peptic Ulcer Disease II: Pathophysiology
1.9K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.9K
Esophageal Perforation-I: Introduction
409
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
409


